Matthäus Willeit

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Major Depressive Disorder

Prefrontal Cortex

Top Venues

British journal of pharmacology

Schizophrenia bulletin

Molecular psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Matthäus Willeit, Ulrich Sauerzopf, Nicole Praschak-Rieder, Ana Weidenauer
The relationship between prefrontal cortex gray matter volume and subcortical dopamine release - an addendum. Molecular psychiatry (2024)
Ana Weidenauer, Ulrich Sauerzopf, Martin Bauer, Carina Bum, Cornelia Diendorfer, Irena Dajic, Lucie Bartova, Alina Kastner, Karsten Bamminger, Lukas Nics, Cecile Philippe, Marcus Hacker, Dan Rujescu, Wolfgang Wadsak, Nicole Praschak-Rieder, Matthäus Willeit
Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic Observation. Schizophrenia bulletin (2024)
Konstantina Bampali, Filip Koniuszewski, Luca L Silva, Sabah Rehman, Florian D Vogel, Thomas Seidel, Petra Scholze, Florian Zirpel, Arthur Garon, Thierry Langer, Matthäus Willeit, Margot Ernst
Tricyclic antipsychotics and antidepressants can inhibit α5-containing GABA A receptors by two distinct mechanisms. British journal of pharmacology 179 (14) (2022)